1. Home
  2. POWL vs TARS Comparison

POWL vs TARS Comparison

Compare POWL & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POWL
  • TARS
  • Stock Information
  • Founded
  • POWL 1947
  • TARS 2016
  • Country
  • POWL United States
  • TARS United States
  • Employees
  • POWL N/A
  • TARS N/A
  • Industry
  • POWL Electrical Products
  • TARS Medicinal Chemicals and Botanical Products
  • Sector
  • POWL Energy
  • TARS Health Care
  • Exchange
  • POWL Nasdaq
  • TARS Nasdaq
  • Market Cap
  • POWL 2.1B
  • TARS 1.7B
  • IPO Year
  • POWL N/A
  • TARS 2020
  • Fundamental
  • Price
  • POWL $248.37
  • TARS $41.50
  • Analyst Decision
  • POWL Strong Buy
  • TARS Strong Buy
  • Analyst Count
  • POWL 1
  • TARS 7
  • Target Price
  • POWL $312.00
  • TARS $67.14
  • AVG Volume (30 Days)
  • POWL 286.5K
  • TARS 564.3K
  • Earning Date
  • POWL 07-29-2025
  • TARS 08-07-2025
  • Dividend Yield
  • POWL 0.43%
  • TARS N/A
  • EPS Growth
  • POWL 68.79
  • TARS N/A
  • EPS
  • POWL 14.23
  • TARS N/A
  • Revenue
  • POWL $1,083,293,000.00
  • TARS $233,674,000.00
  • Revenue This Year
  • POWL $11.52
  • TARS $122.94
  • Revenue Next Year
  • POWL $5.05
  • TARS $44.14
  • P/E Ratio
  • POWL $17.48
  • TARS N/A
  • Revenue Growth
  • POWL 27.43
  • TARS 449.03
  • 52 Week Low
  • POWL $127.41
  • TARS $20.08
  • 52 Week High
  • POWL $364.98
  • TARS $57.28
  • Technical
  • Relative Strength Index (RSI)
  • POWL 72.25
  • TARS 49.39
  • Support Level
  • POWL $212.39
  • TARS $41.50
  • Resistance Level
  • POWL $237.74
  • TARS $43.33
  • Average True Range (ATR)
  • POWL 9.38
  • TARS 1.63
  • MACD
  • POWL 2.00
  • TARS 0.23
  • Stochastic Oscillator
  • POWL 92.26
  • TARS 42.86

About POWL Powell Industries Inc.

Powell Industries Inc is a United States-based company that develops, designs, manufactures, and services custom-engineered equipment and systems for electrical energy distribution, control, and monitoring. The company's principal products comprise integrated power control room substations, custom-engineered modules, electrical houses, traditional and arc-resistant distribution switchgear and control gear, and so on. These products are applied in oil and gas refining, offshore oil and gas production, petrochemical, pipeline, terminal, mining and metals, light-rail traction power, electric utility, pulp and paper, and other heavy industrial markets. The company generates the majority of its sales from the United States, and the rest from Canada, Europe, Asia Pacific, and other regions.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

Share on Social Networks: